Search

Patricia L. Morris

Examiner (ID: 11378)

Most Active Art Unit
1625
Art Unit(s)
1612, 1203, 1201, 1209, 1625
Total Applications
3798
Issued Applications
2697
Pending Applications
142
Abandoned Applications
965

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5771706 [patent_doc_number] => 20050267157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Magnesium-S-omeprazole' [patent_app_type] => utility [patent_app_number] => 10/855809 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20483 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267157.pdf [firstpage_image] =>[orig_patent_app_number] => 10855809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855809
Magnesium-S-omeprazole May 27, 2004 Abandoned
Array ( [id] => 7089773 [patent_doc_number] => 20050009886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => '1,4-Dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety' [patent_app_type] => utility [patent_app_number] => 10/851293 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 13815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009886.pdf [firstpage_image] =>[orig_patent_app_number] => 10851293 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851293
1,4-Dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety May 23, 2004 Abandoned
Array ( [id] => 4705165 [patent_doc_number] => 20080064689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => '3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 11/569148 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34208 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064689.pdf [firstpage_image] =>[orig_patent_app_number] => 11569148 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569148
3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents May 23, 2004 Abandoned
Array ( [id] => 7265108 [patent_doc_number] => 20040242644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => '(IS-5S)-3-(5,6-dichloro-3-pyridinyl-)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent' [patent_app_type] => new [patent_app_number] => 10/851917 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11324 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242644.pdf [firstpage_image] =>[orig_patent_app_number] => 10851917 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851917
(IS-5S)-3-(5,6-dichloro-3-pyridinyl-)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent May 20, 2004 Abandoned
Array ( [id] => 7056504 [patent_doc_number] => 20050277679 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-12-15 [patent_title] => 'Sodium salts of 5-\'4-\'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione' [patent_app_type] => utility [patent_app_number] => 10/849603 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4186 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0277/20050277679.pdf [firstpage_image] =>[orig_patent_app_number] => 10849603 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/849603
Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione May 18, 2004 Abandoned
Array ( [id] => 7056504 [patent_doc_number] => 20050277679 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-12-15 [patent_title] => 'Sodium salts of 5-\'4-\'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione' [patent_app_type] => utility [patent_app_number] => 10/849603 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4186 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0277/20050277679.pdf [firstpage_image] =>[orig_patent_app_number] => 10849603 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/849603
Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione May 17, 2004 Abandoned
Array ( [id] => 7449982 [patent_doc_number] => 20040186288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => '3,5-Diamino-1,2,4-triazoles as kinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/477126 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5437 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20040186288.pdf [firstpage_image] =>[orig_patent_app_number] => 10477126 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477126
3,5-Diamino-1,2,4-triazoles as kinase inhibitors May 17, 2004 Abandoned
Array ( [id] => 7061810 [patent_doc_number] => 20050004172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes' [patent_app_type] => utility [patent_app_number] => 10/847900 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15461 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004172.pdf [firstpage_image] =>[orig_patent_app_number] => 10847900 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/847900
Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes May 16, 2004 Abandoned
Array ( [id] => 4705353 [patent_doc_number] => 20080064877 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2008-03-13 [patent_title] => 'PROCESS FOR THE PREPARATION OF ROSIGLITAZONE' [patent_app_type] => utility [patent_app_number] => 11/579439 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2421 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0064/20080064877.pdf [firstpage_image] =>[orig_patent_app_number] => 11579439 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579439
Process for the Preparation of Rosiglitazone May 11, 2004 Abandoned
Array ( [id] => 7352188 [patent_doc_number] => 20040248945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Thiazolidinedione derivative and its use as antidiabetic' [patent_app_type] => new [patent_app_number] => 10/843741 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2963 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248945.pdf [firstpage_image] =>[orig_patent_app_number] => 10843741 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/843741
Thiazolidinedione derivative and its use as antidiabetic May 11, 2004 Abandoned
Array ( [id] => 4705353 [patent_doc_number] => 20080064877 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2008-03-13 [patent_title] => 'PROCESS FOR THE PREPARATION OF ROSIGLITAZONE' [patent_app_type] => utility [patent_app_number] => 11/579439 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2421 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A2/0064/20080064877.pdf [firstpage_image] =>[orig_patent_app_number] => 11579439 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579439
Process for the Preparation of Rosiglitazone May 11, 2004 Abandoned
Array ( [id] => 5662145 [patent_doc_number] => 20060252741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => '3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists' [patent_app_type] => utility [patent_app_number] => 10/554665 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26448 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252741.pdf [firstpage_image] =>[orig_patent_app_number] => 10554665 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554665
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists May 11, 2004 Abandoned
Array ( [id] => 4628 [patent_doc_number] => 07812016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Naphthyridine integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/556311 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37397 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812016.pdf [firstpage_image] =>[orig_patent_app_number] => 10556311 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556311
Naphthyridine integrase inhibitors May 11, 2004 Issued
Array ( [id] => 7127964 [patent_doc_number] => 20050059708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Processes for making thiazolidinedione derivatives and compounds thereof' [patent_app_type] => utility [patent_app_number] => 10/842635 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7863 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059708.pdf [firstpage_image] =>[orig_patent_app_number] => 10842635 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/842635
Processes for making thiazolidinedione derivatives and compounds thereof May 10, 2004 Abandoned
Array ( [id] => 7216933 [patent_doc_number] => 20050054684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same' [patent_app_type] => utility [patent_app_number] => 10/842696 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4180 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054684.pdf [firstpage_image] =>[orig_patent_app_number] => 10842696 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/842696
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same May 10, 2004 Issued
Array ( [id] => 758215 [patent_doc_number] => 07015237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Pyridine matrix metalloproteinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/842863 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12998 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 496 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015237.pdf [firstpage_image] =>[orig_patent_app_number] => 10842863 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/842863
Pyridine matrix metalloproteinase inhibitors May 9, 2004 Issued
Array ( [id] => 5689039 [patent_doc_number] => 20060287354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Azaindole compounds as kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/556227 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10157 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287354.pdf [firstpage_image] =>[orig_patent_app_number] => 10556227 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556227
Azaindole compounds as kinase inhibitors May 5, 2004 Abandoned
Array ( [id] => 5057634 [patent_doc_number] => 20070060556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Barium salt of benzimidazole derivative' [patent_app_type] => utility [patent_app_number] => 10/555628 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2413 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060556.pdf [firstpage_image] =>[orig_patent_app_number] => 10555628 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555628
Barium salt of benzimidazole derivative May 2, 2004 Abandoned
Array ( [id] => 5662204 [patent_doc_number] => 20060252800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Anti-leishmania agent' [patent_app_type] => utility [patent_app_number] => 10/555539 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7928 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252800.pdf [firstpage_image] =>[orig_patent_app_number] => 10555539 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555539
Anti-leishmania agent Apr 29, 2004 Abandoned
Array ( [id] => 7688621 [patent_doc_number] => 20070106077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Synthesis of substituted heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 10/555740 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8331 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20070106077.pdf [firstpage_image] =>[orig_patent_app_number] => 10555740 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555740
Synthesis of substituted heterocyclic compounds Apr 29, 2004 Issued
Menu